Clinical utility of 18F‐fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience

Ähnliche Einträge

• Correction to “Clinical utility of 18 F ‐fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience”
  Veröffentlicht: (2026)
• Use of fluorine‐18‐fluorodeoxyglucose positron emission tomography/computed tomography in diagnosing giant cell arteritis in a Western Australian tertiary centre: a 36‐month analysis
  von: Madeleine Venables, et al.
  Veröffentlicht: (2025)
• Clinico‐pathologic characteristics, updated diagnostic approach and value of positron emission tomography for adults with splenomegaly at a large, university hospital
  von: Huw Richards, et al.
  Veröffentlicht: (2025)
• Advanced imaging of relapse in giant cell arteritis: The role of vascular adhesion protein‐1 and [68Ga]Ga‐DOTA‐Siglec‐9 positron emission tomography–computed tomography
  von: Simon M. Petzinna, et al.
  Veröffentlicht: (2025)
• Tolerability of subcutaneous teicoplanin administration in an Australian tertiary hospital clinical setting
  von: Sarah S. J. Clark, et al.
  Veröffentlicht: (2025)